Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related AXP
Analysis: Bank Deregulation Is Likely This Year, And Here's What It Might Look Like
The Risks For American Express Are Priced In, Analyst Says In Upgrade
American Express: Strong Operating Trends But Upside Is Limited (Seeking Alpha)
Related POT
22 Stocks Moving In Friday's Pre-Market Session
Wall Street's M&A Chatter From September 13: Tenet, Potash, Oclaro, Lattice Semiconductor

Analysts at Morgan Stanley downgraded American Express Company (NYSE: AXP) from Overweight to Equal-weight. The target price for American Express has been lowered from $88 to $64. American Express shares closed at $55.05 on Friday.

Analysts at JP Morgan downgraded Potash Corporation of Saskatchewan (USA) (NYSE: POT) from Overweight to Neutral. Potash Corporation of Saskatchewan shares closed at $16.09 on Friday.

Nomura downgraded JPMorgan Chase & Co. (NYSE: JPM) from Buy to Neutral. The target price for JPMorgan has been raised to $71. JPMorgan shares closed at $56.92 on Friday.

BMO Capital downgraded Bristol-Myers Squibb Co (NYSE: BMY) from Outperform to Market Perform. Bristol-Myers Squibb shares closed at $64.41 on Friday.

Analysts at Piper Jaffray downgraded Power Solutions International Inc (NASDAQ: PSIX) from Overweight to Neutral. Power Solutions shares closed at $14.52 on Friday.

Analysts at Gabelli & Co downgraded Accuride Corporation (NYSE: ACW) from Buy to Hold. Accuride shares closed at $0.891 on Friday.

Goldman Sachs downgraded Caterpillar Inc. (NYSE: CAT) from Neutral to Sell. Caterpillar shares closed at $60.99 on Friday.

JMP Securities downgraded Toll Brothers Inc (NYSE: TOL) from Outperform to Market Perform. Toll Brothers shares closed at $28.21 on Friday.

Analysts at Stifel Nicolaus downgraded Twitter Inc (NYSE: TWTR) from Buy to Hold. Twitter shares closed at $17.84 on Friday.

Analysts at Chardan Capital downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from Neutral to Sell. The target price for Regeneron Pharmaceuticals has been lowered from $525 to $400. Regeneron Pharmaceuticals shares closed at $482.99 on Friday.

Latest Ratings for AXP

DateFirmActionFromTo
Feb 2018NomuraUpgradesNeutralBuy
Feb 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Jan 2018JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for AXP
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AXP + ACW)

View Comments and Join the Discussion!